These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 3809968

  • 1. The excretion of noradrenergic metabolites, particularly MHPG, in obese children and adolescents.
    Popa M, Stefănescu AM, Tache A, Dumitriu L.
    Endocrinologie; 1986; 24(4):271-80. PubMed ID: 3809968
    [Abstract] [Full Text] [Related]

  • 2. Low level of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children having concomitantly high 3-methoxy-4-hydroxyphenyl glycol (MHPG) excretion.
    Popa M, Stefănescu AM, Dumitriu L.
    Endocrinologie; 1989; 27(1):29-34. PubMed ID: 2474191
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M, Stefănescu AM, Dumitriu L.
    Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
    [Abstract] [Full Text] [Related]

  • 4. Decrease of urinary levels of adrenergic metabolites including conjugated MHPG after a short term course of diethylpropion in obese children fed a mixed, low-calorie diet.
    Popa M, Stefănescu AM, Dumitriu L.
    Endocrinologie; 1987; 25(3):179-86. PubMed ID: 3685848
    [Abstract] [Full Text] [Related]

  • 5. Direct assay of 3-methoxy-4-hydroxy-phenylglycol (MHPG) in human saliva; a new approach in the assessment of noradrenergic function.
    Stefănescu AM, Popa M, Dumitriu L.
    Endocrinologie; 1989; 27(2):93-6. PubMed ID: 2799243
    [Abstract] [Full Text] [Related]

  • 6. The assessment of the dopaminergic tonus by urinary determinations of homovanillic acid (HVA) and dihydroxyphenylacetic acid (DOPAC) in normal, obese and GH-deficient short children.
    Popa M, Stefănescu AM, Dumitriu L, Simionescu L, Giurcăneanu M.
    Endocrinologie; 1988; 26(3):211-20. PubMed ID: 3212382
    [Abstract] [Full Text] [Related]

  • 7. Free 3-methoxy-4-hydroxyphenylglycol (MHPG) in human urine: metabolic routes, biochemical and clinical significance in healthy and obese children.
    Stefănescu AM, Popa M, Dumitriu L.
    Endocrinologie; 1988; 26(2):119-25. PubMed ID: 3413439
    [Abstract] [Full Text] [Related]

  • 8. Changes in the excretion of catecholamines and their metabolites in patients with essential hypertension during sodium intake restriction.
    Wocial B, Januszewicz W, Chodakowska J, Feltynowski T.
    Cor Vasa; 1981; 23(3):222-8. PubMed ID: 6790225
    [Abstract] [Full Text] [Related]

  • 9. Noradrenergic output and clinical response in depressed women during amitriptyline therapy.
    Corona GL, Cucchi ML, Frattini P, Santagostino G, Schinelli S, Comincioli V, Zerbi F, Fenoglio L, Savoldi F.
    Pharmacopsychiatry; 1989 Jul; 22(4):144-51. PubMed ID: 2762377
    [Abstract] [Full Text] [Related]

  • 10. Catecholamine metabolism during heroin use.
    Schildkraut JJ, Meyer RE, Orsulak PJ, Mirin SM, Roffman M, Platz PA, Grab E, Randall ME, McDougle M.
    Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
    [Abstract] [Full Text] [Related]

  • 11. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
    Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA.
    Arch Gen Psychiatry; 1978 Dec; 35(12):1427-33. PubMed ID: 727878
    [Abstract] [Full Text] [Related]

  • 12. Effect of moderate exercise on urinary MHPG in depressed patients.
    Beckmann H, Ebert MH, Post R, Goodwin FK.
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):351-6. PubMed ID: 504341
    [Abstract] [Full Text] [Related]

  • 13. Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
    Schatzberg AF, Orsulak PJ, Rosenbaum AH, Kruger ER, Schildkraut JJ, Cole JO.
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 2):35-9. PubMed ID: 7440524
    [Abstract] [Full Text] [Related]

  • 14. Catecholamine metabolites in spinal cord injury.
    Harvey RF, Fullerton DT, Carlson IH, Klein MH, Howell T.
    Arch Phys Med Rehabil; 1982 Sep; 63(9):419-22. PubMed ID: 7115040
    [Abstract] [Full Text] [Related]

  • 15. [Selective study of sulfate and glucuronide conjugates of urinary MHPG in nervous depression. Peripheral and central influences].
    Peyrin L, Pequignot JM, Chauplannaz G, Laurent B, Moindrot J, Aimard G.
    Encephale; 1985 Sep; 11(1):19-24. PubMed ID: 3996286
    [Abstract] [Full Text] [Related]

  • 16. Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites.
    Maas JW.
    Adv Biochem Psychopharmacol; 1984 Sep; 39():45-55. PubMed ID: 6431762
    [Abstract] [Full Text] [Related]

  • 17. Thyroid hormone-induced reduction of urinary 5-hydroxyindole acetic acid (5 HIAA) in obese children. Comparison with hypothyroid patients of similar age having either pituitary dwarfism or congenital myxedema.
    Popa M, Stefănescu AM, Dumitriu L, Dimitriu V, Bartoc R.
    Endocrinologie; 1989 Sep; 27(1):35-41. PubMed ID: 2474192
    [Abstract] [Full Text] [Related]

  • 18. Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity.
    Gilardini L, Parati G, Sartorio A, Mazzilli G, Pontiggia B, Invitti C.
    J Hum Hypertens; 2008 Feb; 22(2):75-82. PubMed ID: 17882228
    [Abstract] [Full Text] [Related]

  • 19. Effect of supplemental ascorbic acid in a case of torsion dystonia.
    Mars H.
    Adv Neurol; 1976 Feb; 14():319-27. PubMed ID: 941777
    [Abstract] [Full Text] [Related]

  • 20. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N, Nagasaka N.
    ASDC J Dent Child; 1996 Feb; 63(2):118-22. PubMed ID: 8708120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.